The U.S. Food & Drug Administration (FDA) has granted Lumitron Technologies, Inc. the designation of “Breakthrough Device” for its HyperVIEWTM X-Ray system utilizing the K-Edge subtraction technique to enable contrast-enhanced imaging for diagnosis of breast cancer.
Diag-Nose.io, a trailblazer in biotechnology and a distinguished graduate from Stanford University’s EENT Innovation Biodesign program, proudly announces the closure of an oversubscribed $2M seed funding round.
PowerPatent, a pioneer in intellectual property solutions, has announced the launch of its groundbreaking Solutions for Wireless Communication Patents at the prestigious Global Telecom IP Forum.
The A' Medical Devices and Medical Equipment Design Award announces its comprehensive prize package for the 2024-2025 competition period, offering an extensive array of benefits designed to celebrate and promote excellence in medical product design.
The A' Scientific Instruments and Research Equipment Design Award, a highly prestigious international design competition established in 2008, announces its final call for late entries.
Quantum Brilliance (QB), a global leader in mass deployable, room temperature diamond quantum technology, today announced that Dr. Andrew Dunn has been appointed Chief Operating Officer.
Atlas Power Technologies is proud to announce that our innovative supercapacitors made with Atlas’ proprietary dry-electrode technology have been awarded UL 810A certi?cation by the CSA Group.
